fda semaglutide shortage resolved february 2025 announcement As of 21, 2025, the updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A title 🚨 Important Update on

The company also sent text messages containing a link to cancel their subscription to the compounded semaglutide program to all users

Your appetite control should feel noticeably different within the first two weeks of a dose increase

Medications Affecting the Gastrointestinal Tract: Semaglutide can slow down the movement of food through your stomach and intestines

In last months newsletter we highlighted a February 6 statement by Commissioner Makary indicating that the agency would take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies

A previous breast cancer diagnosis raises the likelihood of recurrence

Conclusion Investigations done on antioxidants have shown that these compounds are candidates for the treatment and candidates to prevent oxidative stress-related diseases